IL17A and inflammatory bowel disease: Moreover, in IBD patients, the combination of PGE2, IL-23, and IL-1β works synergistically to enhance IL-17A secretion from CD161+ CD4+ T cells [18] which infiltrate the gastrointestinal tract [19–21].